Thank you, Rossella, I cant wait for our next appointment
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
Improved cognitive function: NAD+ has been shown to support healthy brain function and may help improve memory and cognitive performance
The mixs notable effect, acceptable safety profile, and full body benefits make it an essential component of any cutting-edge obesity research program
Our Cagrilintide is 99% pure as verified by HPLC